Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clive Morris, MD
Inivata
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facey Medical Foundation
Mission Hills, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Eastern Ct Hematology Oncology
Norwich, Connecticut, United States
- Christiana Care Health Services Inc
Newark, Delaware, United States
- Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Mid-Florida Hematology and Oncology Centers
Orange City, Florida, United States
- Swedish Covenant Hospital
Chicago, Illinois, United States
- Edward M Kaplan, Md & Associates
Skokie, Illinois, United States
- Cotton O'Neil Clinical Research Center
Topeka, Kansas, United States
- Norton Healthcare Inc
Louisville, Kentucky, United States
- Christus Cancer Treatment Center
Shreveport, Louisiana, United States
- Berkshire Hematology Oncology Services
Pittsfield, Massachusetts, United States
- Henry Ford Allegiance Health
Jackson, Michigan, United States
- Park Nicolett
Saint Louis Park, Minnesota, United States
- Jackson Oncology Associates, Pllc
Jackson, Mississippi, United States
- Boone Hospital Center
Columbia, Missouri, United States
- Washington University (st. Louis)
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Northshore Hematology Oncology
East Setauket, New York, United States
- Northern Westchester Hospital Association
Mount Kisco, New York, United States
- East Carolina University
Greenville, North Carolina, United States
- Levine Cancer Center
Mint Hill, North Carolina, United States
- Pinehurst Medical Clinic
Pinehurst, North Carolina, United States
- Trinity Cancer Center
Minot, North Dakota, United States
- Providence Health and Services
Portland, Oregon, United States
- Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
- Carolina Blood and Cancer Care
Rock Hill, South Carolina, United States
- the West Clinic
Germantown, Tennessee, United States
- Tennessee Cancer Specialists
Knoxville, Tennessee, United States
- Thomas Spann Clinic Oncology
Corpus Christi, Texas, United States
- Hope Cancer Center of East Texas (tyler Hem Onc)
Tyler, Texas, United States
- Virginia Cancer Institute
Richmond, Virginia, United States
- Providence Regional Medical Center
Everett, Washington, United States
- University of Washington (swedish General)
Seattle, Washington, United States
- Northwest Medical Specialties
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2016
- Primary completion
- 31 May 2018
- Completion
- 31 Dec 2018
- Last update posted
- 16 May 2019
- Registered enrollment
- 264
- Registry id
- NCT02906852
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.